Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma
about
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy.Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells
P2860
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Folic acid phenotype (FAP) is ...... malignant pleural mesothelioma
@ast
Folic acid phenotype (FAP) is ...... malignant pleural mesothelioma
@en
type
label
Folic acid phenotype (FAP) is ...... malignant pleural mesothelioma
@ast
Folic acid phenotype (FAP) is ...... malignant pleural mesothelioma
@en
prefLabel
Folic acid phenotype (FAP) is ...... malignant pleural mesothelioma
@ast
Folic acid phenotype (FAP) is ...... malignant pleural mesothelioma
@en
P2093
P2860
P356
P1433
P1476
Folic acid phenotype (FAP) is ...... malignant pleural mesothelioma
@en
P2093
Claudia Vollbrecht
Daniel Christian Christoph
Elena Flom
Fabian Dominik Mairinger
Helmut Hans Popper
Jens Kollmeier
Kurt-Werner Schmid
Thomas Mairinger
P2860
P304
37502-37510
P356
10.18632/ONCOTARGET.16398
P407
P50
P577
2017-06-01T00:00:00Z